News

The progression of osteoarthritis, which is based on the marker of cartilage degeneration as well as pain, can be forecasted by using the plasma proteomic signature. Researchers from the US have been able to identify a plasma proteomic signature...

The Lancet study is the first to showcase the practical use of prescription medications based on an individual's genetic information. The one-size-fits-all approach to pharmaceutical prescription is out of date. Patients may react differently to a specific medicine due to...

All labelling pertaining to the products that carry the national drug code will have to be updated if in case the FDA finalises its proposed policy to expand the numbers from 10 to 12 digits. There will be some...

NICE, the National Institute for Health and Care Excellence, has received a plea from the Kidney Cancer UK to bring about guidelines on the diagnosis and treatment of kidney cancer as a significant priority. Although NHS England has commissioned NICE...

The Association of the British Pharmaceutical Industry (ABPI) has urged the government to take prompt action in response to the planned UK statutory revenue clawback rate increase for branded medications. The Department of Health and Social Care (DHSC) is now...

A Phase III trial found that pembrolizumab plus chemotherapy enhanced survival in endometrial cancer patients. A Phase III clinical trial comparing pembrolizumab to chemotherapy (carboplatin and paclitaxel) enhanced progression-free survival (PFS) in patients with stage III-IV or recurrent endometrial cancer. As...

An event that hasn’t happened before was demonstrated by researchers from Duke-NUS Medical School, colleagues in Germany, and the National Heart Centre Singapore (NHCS), suggesting that regenerative treatment to restore damaged kidney function could be a sure possibility. In...